NYSE:WAT - Waters Stock Price, News, & Analysis

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters declared that its board has initiated a stock repurchase plan on Tuesday, April 24th 2018, which permits the company to repurchase $3,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 18.2% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's board of directors believes its stock is undervalued.

Waters Co. (NYSE:WAT) announced its quarterly earnings data on Tuesday, July, 24th. The medical instruments supplier reported $1.95 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.03. The medical instruments supplier earned $596.20 million during the quarter, compared to analysts' expectations of $598.73 million. Waters had a net margin of 2.12% and a return on equity of 27.85%. The firm's revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.76 earnings per share. View Waters' Earnings History.

Waters is scheduled to release their next quarterly earnings announcement on Tuesday, October 23rd 2018. View Earnings Estimates for Waters.

Waters will be holding an earnings conference call on Tuesday, October 23rd at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 5176234512.

Waters updated its FY18 earnings guidance on Tuesday, July, 24th. The company provided earnings per share (EPS) guidance of $8.05-8.20 for the period, compared to the Thomson Reuters consensus estimate of $8.18. Waters also updated its Q3 guidance to $1.85-1.95 EPS.

16 analysts have issued 12-month price targets for Waters' stock. Their forecasts range from $190.00 to $230.00. On average, they anticipate Waters' stock price to reach $208.1429 in the next year. This suggests a possible upside of 10.1% from the stock's current price. View Analyst Price Targets for Waters.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 1 sell rating, 12 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Waters.

Some companies that are related to Waters include Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories, Inc. Class B (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).

Waters' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Bank of Montreal Can (0.11%), Aperio Group LLC (0.10%), Copper Rock Capital Partners LLC (0.06%), American Research & Management Co. (0.06%), Andra AP fonden (0.05%) and Investment House LLC (0.04%). Company insiders that own Waters stock include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Ian King, Joann A Reed, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Institutional Ownership Trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Copper Rock Capital Partners LLC, Aperio Group LLC, Andra AP fonden, Bank of Montreal Can, Investment House LLC and American Research & Management Co.. Company insiders that have sold Waters company stock in the last year include Christopher A Kuebler, David Terricciano, Elizabeth B Rae, Eugene G Cassis, Joann A Reed, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Rohit Khanna, Terrence P Kelly, Thomas P Salice and William J Miller. View Insider Buying and Selling for Waters.

WAT stock was acquired by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Personal Capital Advisors Corp, Clinton Group Inc., First Hawaiian Bank and State of Alaska Department of Revenue. View Insider Buying and Selling for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $188.98.

Waters has a market capitalization of $15.00 billion and generates $2.31 billion in revenue each year. The medical instruments supplier earns $20.31 million in net income (profit) each year or $7.49 on an earnings per share basis. Waters employs 7,000 workers across the globe.

The official website for Waters is http://www.waters.com.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]